Poly Medicure Management
Management Kriterienprüfungen 2/4
Poly Medicure's CEO ist Himanshu Baid, ernannt in Sep 1995, hat eine Amtszeit von 28.67 Jahren. Die jährliche Gesamtvergütung beträgt ₹130.06M, bestehend aus 42.3% Gehalt und 57.7% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 12.24% der Aktien des Unternehmens, im Wert von ₹21.09B. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.9 Jahre bzw. 10.9 Jahre.
Wichtige Informationen
Himanshu Baid
Geschäftsführender
₹171.8m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 33.6% |
| Amtszeit als Geschäftsführer | 29yrs |
| Eigentum des Geschäftsführers | 11.6% |
| Durchschnittliche Amtszeit des Managements | 6.3yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 8.9yrs |
Jüngste Management Updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Recent updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹172m | ₹58m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹2b |
| Sep 30 2023 | n/a | n/a | ₹2b |
| Jun 30 2023 | n/a | n/a | ₹2b |
| Mar 31 2023 | ₹130m | ₹55m | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹1b |
| Jun 30 2022 | n/a | n/a | ₹1b |
| Mar 31 2022 | ₹107m | ₹49m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹92m | ₹44m | ₹1b |
| Dec 31 2020 | n/a | n/a | ₹1b |
| Sep 30 2020 | n/a | n/a | ₹1b |
| Jun 30 2020 | n/a | n/a | ₹1b |
| Mar 31 2020 | ₹62m | ₹35m | ₹959m |
| Dec 31 2019 | n/a | n/a | ₹947m |
| Sep 30 2019 | n/a | n/a | ₹858m |
| Jun 30 2019 | n/a | n/a | ₹719m |
| Mar 31 2019 | ₹44m | ₹14m | ₹654m |
| Mar 31 2018 | ₹41m | ₹14m | ₹706m |
Vergütung im Vergleich zum Markt: HimanshuDie Gesamtvergütung ($USD1.57M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD435.24K).
Entschädigung vs. Einkommen: HimanshuDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.
Geschäftsführer
Himanshu Baid (56 yo)
29yrs
Amtszeit
₹171,781,000
Vergütung
Mr. Himanshu Baid has been the Managing Director of Poly Medicure Limited since September 20, 1995 and serves as Chief Executive Officer. Mr. Baid is an Electronics Engineer and has experience in respect t...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, MD & Director | 29yrs | ₹171.78m | 11.6% ₹ 27.3b | |
| Founder & Non Executive Director | no data | ₹1.43m | 2.25% ₹ 5.3b | |
| Chief Financial Officer | 3.2yrs | ₹11.21m | keine Daten | |
| Company Secretary & Compliance Officer | 9.3yrs | ₹1.88m | keine Daten | |
| Joint MD & Executive Director | no data | ₹166.82m | 12.39% ₹ 29.2b | |
| President of Corporate Sales & Marketing | 2.4yrs | ₹18.39m | 1.66% ₹ 3.9b | |
| Assistant Vice President of Finance & Accounts | no data | keine Daten | keine Daten | |
| Senior Vice President of Domestic Sales & Marketing | no data | ₹5.79m | keine Daten | |
| President of R&D | no data | ₹5.61m | keine Daten | |
| President of Sales & Marketing - India | no data | ₹8.61m | keine Daten |
6.3yrs
Durchschnittliche Betriebszugehörigkeit
56yo
Durchschnittliches Alter
Erfahrenes Management: Das Managementteam von POLYMED ist erfahren und erfahren (durchschnittliche Amtszeit: 5.9 Jahre).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, MD & Director | 29.5yrs | ₹171.78m | 11.6% ₹ 27.3b | |
| Founder & Non Executive Director | 29.5yrs | ₹1.43m | 2.25% ₹ 5.3b | |
| Joint MD & Executive Director | 29.5yrs | ₹166.82m | 12.39% ₹ 29.2b | |
| Additional Non Executive and Independent Director | less than a year | keine Daten | keine Daten | |
| Non-Executive Independent Director | 4.3yrs | ₹1.60m | keine Daten | |
| Non-Executive Independent Chairman | 19.3yrs | ₹1.63m | keine Daten | |
| Non-Executive Director | 10.2yrs | ₹1.43m | 3.02% ₹ 7.1b | |
| Non-Executive Independent Director | 12.3yrs | ₹1.50m | keine Daten | |
| Non-Executive Independent Director | 4.1yrs | ₹1.45m | keine Daten | |
| Non-Executive Independent Director | 7.6yrs | ₹1.45m | keine Daten | |
| Non-Executive Non Independent Director | 6.3yrs | ₹29.90m | keine Daten | |
| Independent Director | 2.4yrs | ₹1.45m | keine Daten |
8.9yrs
Durchschnittliche Betriebszugehörigkeit
64yo
Durchschnittliches Alter
Erfahrener Vorstand: POLYMEDDie Vorstandsmitglieder gelten als erfahren (8.9 Jahre durchschnittliche Amtszeit).